Programme

Presentations

08:00

Personalizing immunosuppression in liver transplant recipients: Balancing rejection, infection and malignancy

Simone I. Strasser (AU)

Bio

08:20

Personalizing IS in complex liver transplant cases: Autoimmune disease, NASH, elderly recipients

Marina Berenguer (ES)

Bio

08:40

Tacrolimus intrapatient variability in solid organ transplantation

Juhan Lee (KR)

Bio

Presentations

08:00

Graft-localized programmable immunosuppression enables durable survival in vascularized composite allotransplantation

Vijay Gorantla (US)

Bio Abstract

08:15

What we know and don't but should about cardiac allograft vasculopathy

Kavitha Muthiah (AU)

Bio

08:36

What should we continue to learn from renal allograft pathology

Mariam Alexander (US)

Bio

Presentations

08:00

Latin America

Gustavo Fernandes Ferreira (BR)

Bio

08:10

Europe

Marti Manyalich Vidal (ES)

Bio

08:20

Middle-East - North Africa

Refaat Kamel (EG)

Bio

08:30

Asia

Susumu Eguchi (JP)

Bio

08:40

Oceania

Helen Opdam (AU)

Bio

08:50

North America

Atul Humar (CA)

Bio

Presentations

09:15

Why survival alone is not sufficient for transplant successs

Mariel Nöhre (DE)

Bio

09:30

Psychological distress across the transplant journey

Iris Fontanilla (NZ)

Bio

09:45

Practical strategies for integrating mental health in transplant care

Ming Hwei Yek (US)

Bio

10:00

Panel Discussion

Discussion Period (AU)

Bio

Presentations

09:15

25 years of innovation: The St. Louis donor care unit

Gary F. Marklin (US)

Bio

09:35

The US donor care unit landscape

Jennifer Prinz (US)

Bio

09:55

The first comprehensive-DCU developed in China leading the change of the procurement model

Hui Li (CN)

Bio

10:10

Panel Discussion

Discussion Period (AU)

Bio

Presentations

11:00

Potential donors: Controlled and un-Controlled

Marti Manyalich Vidal (ES)

Bio

11:10

Role of ICU physicians

Sara Alcantara Carmona (ES)

Bio

11:20

Ethics for DCD: How to advance?

David Thomson (ZA)

Bio

11:30

Who should Canulate?

Lilia Martinez de la Maza (SE)

Bio

11:40

Which organs to implant, which ones to pump after NRP

Joaquim Albiol (ES)

Bio

11:50

Question Period

Discussion Period (AU)

Bio

Presentations

11:00

Does metabolic phenotype in the kidney affect transplant outcome?

Ana Konvalinka (CA)

Bio

11:20

Endogenous peptides in T cell allorecognition and beyond – Lessons from preclinical models

Alexandra Sharland (AU)

Bio

11:40

What metabolic interactions drives fibrosis and repair in organ transplantation?

Ton J. Rabelink (NL)

Bio

Presentations

11:00

Structure, achievements, goals – Getting your work published, recognized and highlighted

Stefan Tullius (US)

Bio

11:20

Transplant-Direct: The online campaign journal with an own agenda

Edward Geissler (DE)

Bio

11:40

AI and publishing: When, how and what is legit?

Germaine Wong (AU)

Bio

Presentations

13:30

Introduction and framing / Panel discussant

Fadi Lakkis (US)

Bio

Structured Questions for the Panelists

Discussion Period (AU)

Bio

Panel discussant

Friederike Martin (DE)

Bio

Panel discussant

Gomathy Narasimhan (IN)

Bio

Panelist

Angela Webster (AU)

Bio

Panelist

Karen Dwyer (AU)

Bio

Panel discussant

Shruti Tapiawala (IN)

Bio

Q&A questions from the audience

Discussion Period (AU)

Bio

13:50

Closing remarks

Natasha Rogers (AU)

Bio

Presentations

13:30

Opening remarks and overview: From fragmented data to global alignment. Why transplant registries need a shared framework

Sang Joseph Kim (CA)

Bio

13:40

Creating a transplant registry: Defining purpose, scope, and sustainable infrastructure

Germaine Wong (AU)

Bio

13:50

Establishing trust: Governance, ethics, and legal architecture of transplant registries

Axel Rahmel (DE)

Bio

14:00

Designing registries that work: Data architecture, harmonization, and operational feasibility

Jon Snyder (US)

Bio

14:10

Using registry data responsibly: Methodology, bias mitigation, and meaningful interpretation

Allan Massie (US)

Bio

14:20

From aspirational standards to practical assessment: Introducing the transplant registry maturity model

Yee Lu (US)

Bio

14:30

Panel Discussion

Discussion Period (AU)

Bio

Panelist

Nicole Jane Scholes-Robertson (AU)

Bio

Presentations

15:30

ABO antigens and antibodies: Updating old dogmas

Anne Halpin (CA)

Bio

15:50

Beyond HLA: Adaptive sequencing for blood group profiling in transplantation

Karen Sherwood (CA)

Bio

16:10

ABO incompatible kidney transplantation, strategies and successes

Marta Crespo Barrio (ES)

Bio

Presentations

15:30

ECPR-driven growth in the donor pool

Alvaro Perazzo (BR)

Bio

15:45

Diagnosing brain death in the ECMO patient

Kavitha Muthiah (AU)

Bio

16:00

The role of NRP and machine perfusion in cardiothoracic transplantation

Sandra Lindstedt (SE)

Bio

16:15

Complex decisions: Ethical dilemmas of ECMO, DCD and NRP donors

Emily Granger (AU)

Bio

Presentations

16:45

Do women do better or worse – What the data say across cancer and transplant?

Brenda Maria Rosales (AU)

Bio

17:03

From association to causation: Sex, cancer and transplant outcomes

Craig Coorey (AU)

Bio

17:21

Screening, hormones, and birth plans: a playbook for female recipients

Sakhee Kotecha (AU)

Bio

17:39

Post transplant care: Patient perspectives

Nicole Jane Scholes-Robertson (AU)

Bio

Presentations

16:45

Introduction

Karen Dwyer (AU)

Bio

Introduction

Amanda Sluiter (AU)

Bio

16:48

Panelist

Nuria Montero (ES)

Bio

16:51

Panelist

Zhejia Tian (DE)

Bio

16:54

Panelists

Maria Simonenko (RU)

Bio

16:57

Panelist

Penny Figtree (AU)

Bio

17:00

Panelist

Emma Tumilty (AU)

Bio

17:03

Panelist

John Lafferty (AU)

Bio

17:06

Panelist

Patricia Scheetz (AU)

Bio

17:09

Moderator/Panelist

Karen Dwyer (AU)

Bio

Moderator/Panelist

Brenda Maria Rosales (AU)

Bio

Moderator/Panelist

Amanda Sluiter (AU)

Bio

17:50

Closing discussion

Karen Dwyer (AU)

Bio

Presentations

16:45

The global interdependence of health and the burden of kidney disease as a pressing public health priority

Benita Padilla (PH)

Bio

17:03

Transplant knowledge and skills transfer: the role of collaborative partnerships in reducing disparities in kidney disease-related morbidity and mortality

Shyam Bihari Bansal (IN)

Bio

17:21

Overcoming the challenges in achieving equity in global access to kidney transplantation

Beatriz Domínguez-Gil (ES)

Bio

17:39

Sustainable and scalable models for establishing kidney transplant programs in resource-limited contexts

John S. Gill (CA)

Bio

Presentations

08:00

Implementing change and managing resources: Can we do both?

Alfred Kow (SG)

Bio

08:20

Defining value in liver transplantation: Focusing on what matters

Julie K. Heimbach (US)

Bio

08:40

Telemedicine and remote monitoring: the potential of digital health tools to optimise patient care

Brooke Huuskes (AU)

Bio

Presentations

08:00

Partial heart transplant in children

Edo Bedzra (US)

Bio

08:20

The micorbiome and transplantation

Maria-Luisa Alegre (US)

Bio

08:40

Regulatory cell therapy for solid organ transplantation

Fadi Issa (GB)

Bio

Presentations

Presenting the XenoPrize

Wayne J. Hawthorne (AU)

Bio

2025 Carl-Gustav Groth Xeno Prize for the paper on "Desensitization with Proteasome Inhibition and Costimulation Blockade Modulates the Xenoreactive Humoral Response in Nonhuman Primate Xenotransplantation"

Brendan P. Lovasik (US)

Bio Overview

11:05

Development of the gene edited pigs to get us to the clinic

Peter Cowan (AU)

Bio

11:25

Avoiding dysregulation of the complement and coagulation-anticoagulation systems?

Jo Tector (US)

Bio

11:45

The road to regulatory approval for clinical transplantation

Muhammad Mohiuddin (US)

Bio

Presentations

11:00

Global observatory on donation and transplantation (GODT)

Beatriz Domínguez-Gil (ES)

Bio Overview

11:15

Global donation and transplantation activities. An assessment of 2024 GODT data

Friederike Martin (DE)

Bio Overview

11:40

Panelist

John J. Fung (US)

Bio

Panelists

Nadey Hakim (GB)

Bio

Panelist

David Thomson (ZA)

Bio

Panelist

Dimitri A. Raptis (SA)

Bio

Presentations

11:00

Setting the stage: Older organs - clinical need, ethical and economic considerations

Krista Lentine (US)

Bio

11:20

Objective quality criteria of old organs

Varvara Kirchner (US)

Bio

11:40

Old organs and ex vivo treatment

Jasper Iske (DE)

Bio

Presentations

13:30

The long-term transplant journey: What patients experience after discharge

Liz Schick (CH)

Bio

13:45

Movement when endurance is limited: Finding confidence through everyday activity

Geoff Jessup (AU)

Bio

14:00

From recovery to endurance sport: The transformative role of movement

Kate Clark (AU)

Bio

14:15

Clinical perspective: Encouraging safe physical activity after transplant

Geoffrey McCaughan (AU)

Bio

14:30

Panel discussion: Supporting all patients to move

Discussion Period (AU)

Bio Overview

Presentations

13:30

Climate change and the changing epidemiology of transplant infections

Wanessa T. Clemente (BR)

Bio

13:50

On the move: Migration and the globalization of emerging pathogens

Monica Slavin (AU)

Bio

14:10

New outbreaks of old diseases: Measles and other re-emerging threats in transplantation

Cameron R. Wolfe (US)

Bio

14:30

Disease X and vaccine

Deepali Kumar (CA)

Bio

Presentations

13:30

Global organ sharing & research collaborations

Axel Rahmel (DE)

Bio

13:50

Economics of transplantation

Vasanthi Ramesh (IN)

Bio

14:10

Capacity building in low-resource settings

Medhat Askar (US)

Bio

14:30

Ethical, cultural & patient-centered considerations

Jeremy Chapman (AU)

Bio

Presentations

15:30

Single cell transcriptomic profiling focusing on donor reactive T cells of operational tolerance recipient after liver transplantation

Naoki Tanimine (JP)

Bio Abstract

15:40

🎗10-year outcomes for autologous polyclonal ex-vivo-expanded Treg cellular therapy in renal transplantation (ONE study UK Treg Trial)

Charlotte Yates (GB)

Bio Abstract

15:50

Single cell spatial technologies in kidney allograft pathology- inflammation, fibrosis and beyond

Mariam Alexander (US)

Bio

16:10

Direct and indirect allorecognition – more alike than we thought?

Gavin Pettigrew (GB)

Bio

Presentations

15:30

Assessing risk and overcoming barriers in pregnancy after kidney transplantation

Shilpanjali Jesudason (AU)

Bio

15:50

Pregnancy after kidney transplantation: Beyond clinical outcomes—understanding barriers and experiences of first nations women

Nishanta Tangirala (AU)

Bio

Co-presenting on Pregnancy after kidney transplantation: Beyond clinical outcomes—understanding barriers and experiences of first nations women

Kelli Owen (AU)

Bio

16:10

Supporting pregnancy in transplant recipients: current best practice care and controversies

Sumoyee Basu (GB)

Bio

Presentations

16:45

The challenge of siloed program building vs. opportunities of integration

Markus Selzner (CA)

Bio

16:57

Immunologic bridge

Rajdeep Das (US)

Bio

17:09

One pathogen, two populations

Monica Slavin (AU)

Bio

17:21

Beyond the graft

Teun van Gelder (NL)

Bio

17:33

Panel discussion on global perspectives on integration and innovation

Discussion Period (AU)

Bio

Presentations

16:45

Conversations around kidney transplant evaluation: Who and how to communicate non-eligibility for transplant

Rhiannon Reed (US)

Bio

17:02

Palliative care post-transplant: Throughout patient journey and symptom management

Kathryn Ducharlet (AU)

Bio

17:19

Navigating through organ failure to transplant: Liver transplant

Suk Kyun Hong (KR)

Bio

17:36

Navigating conversations on cardiac mechanical support therapy to heart transplant

Shunichi Nakagawa (US)

Bio

Presentations

08:00

The American perspective

Robert A. Montgomery (US)

Bio

08:12

The European perspective

Jiri Fronek (CZ)

Bio

08:24

The Asian perspective

Ashwin Rammohan (IN)

Bio

08:36

The Oceania perspective

Henry Pleass (AU)

Bio

08:48

Panel discussion

Discussion Period (AU)

Bio

Presentations

08:00

Obesity, diabetes and MAFLD- A target or bystander?

Dinesh Jothimani (IN)

Bio

08:20

Getting the right patients to transplant: Patient selection, pre-transplant evaluation, and organ allocation in MAFLD

Kymberly Watt (US)

Bio

08:40

Optimising outcomes in patients with obesity after transplant: lifestyle modification, bariatric surgery or lifelong GLP1 therapy?

Marina Berenguer (ES)

Bio

Presentations

08:00

AFRAN: Who we are and what we offer

Intissar Haddiya (MA)

Bio

08:08

Rwanda

Emmanuel Muhawenimana (RW)

Bio

08:16

Ethiopia

Mekdim Tadesse Siyoum (ET)

Bio

08:24

Nigeria

Olalekan Olatise (NG)

Bio

Egypt

Refaat Kamel (EG)

Bio

08:40

Panel discussion

Discussion Period (AU)

Bio

Panelist

Nadey Hakim (GB)

Bio

Presentations

08:00

Pearls from the BK guidelines

Nassim Kamar (FR)

Bio

08:15

Pearls from the CMV guidelines

Camille N. Kotton (US)

Bio

08:30

Beyond the guidelines- new developments and future directions: BK

Germaine Wong (AU)

Bio

08:45

Beyond the guidelines - new developments and future directions: CMV

Atul Humar (CA)

Bio

09:00

Panel discussion: challenging BK case, challenging CMV case

Discussion Period (AU)

Bio

Presentations

09:10

Vitalink: Who we are and what we offer

Curie Ahn (KR)

Bio

09:18

Philippines

Rose Marie Rosete-Liquete (PH)

Bio

09:26

Indonesia

Henny Puspitasari (ID)

Bio

09:34

Vietnam

Thu Du (VN)

Bio

09:42

Fiji

Anis Ta'eed (FJ)

Bio

09:50

Panel Discussion

Discussion Period (AU)

Bio

Presentations

09:15

Importance of HLA beyond the A/B/DR

Anat Tambur (US)

Bio

09:35

Beyond HLA: Expanding the immunologic landscape

Toby Coates (AU)

Bio

09:55

Precision risk stratification

Wai Lim (AU)

Bio

Presentations

09:15

Special features: A reality check on opportunities and challenges

Fadi Issa (GB)

Bio

09:27

Social media: Are we reaching our audience and readership worldwide

Jasper Iske (DE)

Bio

09:39

Editorial fellowships: A great opportunity to be involved

Melanie Wyld (AU)

Bio

09:51

Topic highlights – Article series

Camille N. Kotton (US)

Bio

10:03

Panel discussion

Discussion Period (AU)

Bio

Presentations

10:45

Current status of pancreas transplantation: Activity and outcomes around the world

Angelika C. Gruessner (US)

Bio

11:10

Donation after circulatory death (DCD) in pancreas transplantation: Logistics, use of normothermic regional perfusion (NRP) and outcomes

Joana Ferrer (ES)

Bio

11:35

Future of pancreas transplantation in the landscape of emerging therapies

Raja Kandaswamy (US)

Bio

Presentations

14:05

Alagille syndrome - past, present and future

Susan Mei-Ling Siew (AU)

Bio

14:25

Progressive familiar intrahepatic cholestasis differences around the world and the role of medical vs. surgical therapy

Mohamed Rela (IN)

Bio

14:45

Primary sclerosing cholangiotis in children and adolescent

Michael Stormon (AU)

Bio

Presentations

13:45

Canadian donation perspective

Matthew Weiss (CA)

Bio

14:00

Australian donation perspective

Wade Stedman (AU)

Bio

14:15

New Zealand donation perspective

Kim Grayson (NZ)

Bio

14:30

Australian MAID/VAD provider perspective

Sara Townend (AU)

Bio

14:45

Panel discussion and Q&A

Discussion Period (AU)

Bio